img

Human Vaccine


Published on: 2024-01-04 | No of Pages : 149 | Industry : Pharma & Healthcare

Publisher : HNY Research | Format : PDF&Excel

Human Vaccine

The global Human Vaccine market was valued at 137.91 Million USD in 2021 and will grow with a CAGR of 9.78% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body`s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (exampleto prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).The average price of China Human Vaccine is in the increasing trend, from 4.14 USD/Dose in 2013 to 4.49 USD/Dose in 2017. With the situation of global economy, prices will be in increasing trend in the following five years. The classification of China Human Vaccine includes Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine and other kinds of vaccines, and the proportion of Rabies in 2017 is about 20.4%, and the proportion is in fluctuation trend from 2013 to 2017.

By Market Verdors

CNBG

Changsheng Life

Zhifei

ChengDa Bio

Kangtai

SINOVAC BIOTECH

Hissen

Walvax Biotechnology

GSK

SANOFI

Rong An

NuoCheng Bio

Hualan Bio

Tiantan biological

Changchun Baike

Adimmune

Zhongyianke Biotech



By Types

Varicella

Influenza

Polio

Hepatitis A

Rabies

BCG

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal



By Applications

Adults

Children



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Human Vaccine Market Size Analysis from 2022 to 2027

1.5.1 Global Human Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Human Vaccine Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Human Vaccine Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Human Vaccine Industry Impact

Chapter 2 Global Human Vaccine Competition by Types, Applications, and Top Regions and Countries

2.1 Global Human Vaccine (Volume and Value) by Type

2.1.1 Global Human Vaccine Consumption and Market Share by Type (2016-2021)

2.1.2 Global Human Vaccine Revenue and Market Share by Type (2016-2021)

2.2 Global Human Vaccine (Volume and Value) by Application

2.2.1 Global Human Vaccine Consumption and Market Share by Application (2016-2021)

2.2.2 Global Human Vaccine Revenue and Market Share by Application (2016-2021)

2.3 Global Human Vaccine (Volume and Value) by Regions

2.3.1 Global Human Vaccine Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Human Vaccine Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Human Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Human Vaccine Consumption by Regions (2016-2021)

4.2 North America Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Human Vaccine Sales, Consumption, Export, Import (2016-2021)

4.10 South America Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Human Vaccine Market Analysis

5.1 North America Human Vaccine Consumption and Value Analysis

5.1.1 North America Human Vaccine Market Under COVID-19

5.2 North America Human Vaccine Consumption Volume by Types

5.3 North America Human Vaccine Consumption Structure by Application

5.4 North America Human Vaccine Consumption by Top Countries

5.4.1 United States Human Vaccine Consumption Volume from 2016 to 2021

5.4.2 Canada Human Vaccine Consumption Volume from 2016 to 2021

5.4.3 Mexico Human Vaccine Consumption Volume from 2016 to 2021

Chapter 6 East Asia Human Vaccine Market Analysis

6.1 East Asia Human Vaccine Consumption and Value Analysis

6.1.1 East Asia Human Vaccine Market Under COVID-19

6.2 East Asia Human Vaccine Consumption Volume by Types

6.3 East Asia Human Vaccine Consumption Structure by Application

6.4 East Asia Human Vaccine Consumption by Top Countries

6.4.1 China Human Vaccine Consumption Volume from 2016 to 2021

6.4.2 Japan Human Vaccine Consumption Volume from 2016 to 2021

6.4.3 South Korea Human Vaccine Consumption Volume from 2016 to 2021

Chapter 7 Europe Human Vaccine Market Analysis

7.1 Europe Human Vaccine Consumption and Value Analysis

7.1.1 Europe Human Vaccine Market Under COVID-19

7.2 Europe Human Vaccine Consumption Volume by Types

7.3 Europe Human Vaccine Consumption Structure by Application

7.4 Europe Human Vaccine Consumption by Top Countries

7.4.1 Germany Human Vaccine Consumption Volume from 2016 to 2021

7.4.2 UK Human Vaccine Consumption Volume from 2016 to 2021

7.4.3 France Human Vaccine Consumption Volume from 2016 to 2021

7.4.4 Italy Human Vaccine Consumption Volume from 2016 to 2021

7.4.5 Russia Human Vaccine Consumption Volume from 2016 to 2021

7.4.6 Spain Human Vaccine Consumption Volume from 2016 to 2021

7.4.7 Netherlands Human Vaccine Consumption Volume from 2016 to 2021

7.4.8 Switzerland Human Vaccine Consumption Volume from 2016 to 2021

7.4.9 Poland Human Vaccine Consumption Volume from 2016 to 2021

Chapter 8 South Asia Human Vaccine Market Analysis

8.1 South Asia Human Vaccine Consumption and Value Analysis

8.1.1 South Asia Human Vaccine Market Under COVID-19

8.2 South Asia Human Vaccine Consumption Volume by Types

8.3 South Asia Human Vaccine Consumption Structure by Application

8.4 South Asia Human Vaccine Consumption by Top Countries

8.4.1 India Human Vaccine Consumption Volume from 2016 to 2021

8.4.2 Pakistan Human Vaccine Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Human Vaccine Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Human Vaccine Market Analysis

9.1 Southeast Asia Human Vaccine Consumption and Value Analysis

9.1.1 Southeast Asia Human Vaccine Market Under COVID-19

9.2 Southeast Asia Human Vaccine Consumption Volume by Types

9.3 Southeast Asia Human Vaccine Consumption Structure by Application

9.4 Southeast Asia Human Vaccine Consumption by Top Countries

9.4.1 Indonesia Human Vaccine Consumption Volume from 2016 to 2021

9.4.2 Thailand Human Vaccine Consumption Volume from 2016 to 2021

9.4.3 Singapore Human Vaccine Consumption Volume from 2016 to 2021

9.4.4 Malaysia Human Vaccine Consumption Volume from 2016 to 2021

9.4.5 Philippines Human Vaccine Consumption Volume from 2016 to 2021

9.4.6 Vietnam Human Vaccine Consumption Volume from 2016 to 2021

9.4.7 Myanmar Human Vaccine Consumption Volume from 2016 to 2021

Chapter 10 Middle East Human Vaccine Market Analysis

10.1 Middle East Human Vaccine Consumption and Value Analysis

10.1.1 Middle East Human Vaccine Market Under COVID-19

10.2 Middle East Human Vaccine Consumption Volume by Types

10.3 Middle East Human Vaccine Consumption Structure by Application

10.4 Middle East Human Vaccine Consumption by Top Countries

10.4.1 Turkey Human Vaccine Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Human Vaccine Consumption Volume from 2016 to 2021

10.4.3 Iran Human Vaccine Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Human Vaccine Consumption Volume from 2016 to 2021

10.4.5 Israel Human Vaccine Consumption Volume from 2016 to 2021

10.4.6 Iraq Human Vaccine Consumption Volume from 2016 to 2021

10.4.7 Qatar Human Vaccine Consumption Volume from 2016 to 2021

10.4.8 Kuwait Human Vaccine Consumption Volume from 2016 to 2021

10.4.9 Oman Human Vaccine Consumption Volume from 2016 to 2021

Chapter 11 Africa Human Vaccine Market Analysis

11.1 Africa Human Vaccine Consumption and Value Analysis

11.1.1 Africa Human Vaccine Market Under COVID-19

11.2 Africa Human Vaccine Consumption Volume by Types

11.3 Africa Human Vaccine Consumption Structure by Application

11.4 Africa Human Vaccine Consumption by Top Countries

11.4.1 Nigeria Human Vaccine Consumption Volume from 2016 to 2021

11.4.2 South Africa Human Vaccine Consumption Volume from 2016 to 2021

11.4.3 Egypt Human Vaccine Consumption Volume from 2016 to 2021

11.4.4 Algeria Human Vaccine Consumption Volume from 2016 to 2021

11.4.5 Morocco Human Vaccine Consumption Volume from 2016 to 2021

Chapter 12 Oceania Human Vaccine Market Analysis

12.1 Oceania Human Vaccine Consumption and Value Analysis

12.2 Oceania Human Vaccine Consumption Volume by Types

12.3 Oceania Human Vaccine Consumption Structure by Application

12.4 Oceania Human Vaccine Consumption by Top Countries

12.4.1 Australia Human Vaccine Consumption Volume from 2016 to 2021

12.4.2 New Zealand Human Vaccine Consumption Volume from 2016 to 2021

Chapter 13 South America Human Vaccine Market Analysis

13.1 South America Human Vaccine Consumption and Value Analysis

13.1.1 South America Human Vaccine Market Under COVID-19

13.2 South America Human Vaccine Consumption Volume by Types

13.3 South America Human Vaccine Consumption Structure by Application

13.4 South America Human Vaccine Consumption Volume by Major Countries

13.4.1 Brazil Human Vaccine Consumption Volume from 2016 to 2021

13.4.2 Argentina Human Vaccine Consumption Volume from 2016 to 2021

13.4.3 Columbia Human Vaccine Consumption Volume from 2016 to 2021

13.4.4 Chile Human Vaccine Consumption Volume from 2016 to 2021

13.4.5 Venezuela Human Vaccine Consumption Volume from 2016 to 2021

13.4.6 Peru Human Vaccine Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Human Vaccine Consumption Volume from 2016 to 2021

13.4.8 Ecuador Human Vaccine Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Human Vaccine Business

14.1 CNBG

14.1.1 CNBG Company Profile

14.1.2 CNBG Human Vaccine Product Specification

14.1.3 CNBG Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Changsheng Life

14.2.1 Changsheng Life Company Profile

14.2.2 Changsheng Life Human Vaccine Product Specification

14.2.3 Changsheng Life Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Zhifei

14.3.1 Zhifei Company Profile

14.3.2 Zhifei Human Vaccine Product Specification

14.3.3 Zhifei Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 ChengDa Bio

14.4.1 ChengDa Bio Company Profile

14.4.2 ChengDa Bio Human Vaccine Product Specification

14.4.3 ChengDa Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Kangtai

14.5.1 Kangtai Company Profile

14.5.2 Kangtai Human Vaccine Product Specification

14.5.3 Kangtai Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 SINOVAC BIOTECH

14.6.1 SINOVAC BIOTECH Company Profile

14.6.2 SINOVAC BIOTECH Human Vaccine Product Specification

14.6.3 SINOVAC BIOTECH Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Hissen

14.7.1 Hissen Company Profile

14.7.2 Hissen Human Vaccine Product Specification

14.7.3 Hissen Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Walvax Biotechnology

14.8.1 Walvax Biotechnology Company Profile

14.8.2 Walvax Biotechnology Human Vaccine Product Specification

14.8.3 Walvax Biotechnology Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 GSK

14.9.1 GSK Company Profile

14.9.2 GSK Human Vaccine Product Specification

14.9.3 GSK Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 SANOFI

14.10.1 SANOFI Company Profile

14.10.2 SANOFI Human Vaccine Product Specification

14.10.3 SANOFI Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Rong An

14.11.1 Rong An Company Profile

14.11.2 Rong An Human Vaccine Product Specification

14.11.3 Rong An Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 NuoCheng Bio

14.12.1 NuoCheng Bio Company Profile

14.12.2 NuoCheng Bio Human Vaccine Product Specification

14.12.3 NuoCheng Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Hualan Bio

14.13.1 Hualan Bio Company Profile

14.13.2 Hualan Bio Human Vaccine Product Specification

14.13.3 Hualan Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Tiantan biological

14.14.1 Tiantan biological Company Profile

14.14.2 Tiantan biological Human Vaccine Product Specification

14.14.3 Tiantan biological Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Changchun Baike

14.15.1 Changchun Baike Company Profile

14.15.2 Changchun Baike Human Vaccine Product Specification

14.15.3 Changchun Baike Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Adimmune

14.16.1 Adimmune Company Profile

14.16.2 Adimmune Human Vaccine Product Specification

14.16.3 Adimmune Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 Zhongyianke Biotech

14.17.1 Zhongyianke Biotech Company Profile

14.17.2 Zhongyianke Biotech Human Vaccine Product Specification

14.17.3 Zhongyianke Biotech Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Human Vaccine Market Forecast (2022-2027)

15.1 Global Human Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Human Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Human Vaccine Value and Growth Rate Forecast (2022-2027)

15.2 Global Human Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Human Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Human Vaccine Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Human Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Human Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Human Vaccine Consumption Forecast by Type (2022-2027)

15.3.2 Global Human Vaccine Revenue Forecast by Type (2022-2027)

15.3.3 Global Human Vaccine Price Forecast by Type (2022-2027)

15.4 Global Human Vaccine Consumption Volume Forecast by Application (2022-2027)

15.5 Human Vaccine Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology



List of Figure

Figure Product Picture

Figure North America Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure United States Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Canada Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Mexico Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure East Asia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure China Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Japan Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure South Korea Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Europe Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Germany Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure UK Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure France Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Italy Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Russia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Spain Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Netherlands Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Switzerland Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Poland Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure South Asia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure India Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Pakistan Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Bangladesh Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Southeast Asia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Indonesia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Thailand Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Singapore Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Malaysia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Philippines Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Vietnam Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Myanmar Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Middle East Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Turkey Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Saudi Arabia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Iran Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure United Arab Emirates Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Israel Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Iraq Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Qatar Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Kuwait Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Oman Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Africa Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Nigeria Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure South Africa Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Egypt Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Algeria Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Algeria Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Oceania Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Australia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure New Zealand Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure South America Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Brazil Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Argentina Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Columbia Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Chile Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Venezuela Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Peru Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Puerto Rico Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Ecuador Human Vaccine Revenue ($) and Growth Rate (2022-2027)

Figure Global Human Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume

Figure Global Human Vaccine Market Size Analysis from 2022 to 2027 by Value

Table Global Human Vaccine Price Trends Analysis from 2022 to 2027

Table Global Human Vaccine Consumption and Market Share by Type (2016-2021)

Table Global Human Vaccine Revenue and Market Share by Type (2016-2021)

Table Global Human Vaccine Consumption and Market Share by Application (2016-2021)

Table Global Human Vaccine Revenue and Market Share by Application (2016-2021)

Table Global Human Vaccine Consumption and Market Share by Regions (2016-2021)

Table Global Human Vaccine Revenue and Market Share by Regions (2016-2021)

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Major Manufacturers Capacity and Total Capacity

Table 2016-2021 Major Manufacturers Capacity Market Share

Table 2016-2021 Major Manufacturers Production and Total Production

Table 2016-2021 Major Manufacturers Production Market Share

Table 2016-2021 Major Manufacturers Revenue and Total Revenue

Table 2016-2021 Major Manufacturers Revenue Market Share

Table 2016-2021 Regional Market Capacity and Market Share

Table 2016-2021 Regional Market Production and Market Share

Table 2016-2021 Regional Market Revenue and Market Share

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2016-2021 Capacity, Production and Growth Rate

Figure 2016-2021 Revenue, Gross Margin and Growth Rate

Table Global Human Vaccine Consumption by Regions (2016-2021)

Figure Global Human Vaccine Consumption Share by Regions (2016-2021)

Table North America Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table East Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table Europe Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table South Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table Southeast Asia Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table Middle East Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table Africa Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table Oceania Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Table South America Human Vaccine Sales, Consumption, Export, Import (2016-2021)

Figure North America Human Vaccine Consumption and Growth Rate (2016-2021)

Figure North America Human Vaccine Revenue and Growth Rate (2016-2021)

Table North America Human Vaccine Sales Price Analysis (2016-2021)

Table North America Human Vaccine Consumption Volume by Types

Table North America Human Vaccine Consumption Structure by Application

Table North America Human Vaccine Consumption by Top Countries

Figure United States Human Vaccine Consumption Volume from 2016 to 2021

Figure Canada Human Vaccine Consumption Volume from 2016 to 2021

Figure Mexico Human Vaccine Consumption Volume from 2016 to 2021

Figure East Asia Human Vaccine Consumption and Growth Rate (2016-2021)

Figure East Asia Human Vaccine Revenue and Growth Rate (2016-2021)

Table East Asia Human Vaccine Sales Price Analysis (2016-2021)

Table East Asia Human Vaccine Consumption Volume by Types

Table East Asia Human Vaccine Consumption Structure by Application

Table East Asia Human Vaccine Consumption by Top Countries

Figure China Human Vaccine Consumption Volume from 2016 to 2021

Figure Japan Human Vaccine Consumption Volume from 2016 to 2021

Figure South Korea Human Vaccine Consumption Volume from 2016 to 2021

Figure Europe Human Vaccine Consumption and Growth Rate (2016-2021)

Figure Europe Human Vaccine Revenue and Growth Rate (2016-2021)

Table Europe Human Vaccine Sales Price Analysis (2016-2021)

Table Europe Human Vaccine Consumption Volume by Types

Table Europe Human Vaccine Consumption Structure by Application

Table Europe Human Vaccine Consumption by Top Countries

Figure Germany Human Vaccine Consumption Volume from 2016 to 2021

Figure UK Human Vaccine Consumption Volume from 2016 to 2021

Figure France Human Vaccine Consumption Volume from 2016 to 2021

Figure Italy Human Vaccine Consumption Volume from 2016 to 2021

Figure Russia Human Vaccine Consumption Volume from 2016 to 2021

Figure Spain Human Vaccine Consumption Volume from 2016 to 2021

Figure Netherlands Human Vaccine Consumption Volume from 2016 to 2021

Figure Switzerland Human Vaccine Consumption Volume from 2016 to 2021

Figure Poland Human Vaccine Consumption Volume from 2016 to 2021

Figure South Asia Human Vaccine Consumption and Growth Rate (2016-2021)

Figure South Asia Human Vaccine Revenue and Growth Rate (2016-2021)

Table South Asia Human Vaccine Sales Price Analysis (2016-2021)

Table South Asia Human Vaccine Consumption Volume by Types

Table South Asia Human Vaccine Consumption Structure by Application

Table South Asia Human Vaccine Consumption by Top Countries

Figure India Human Vaccine Consumption Volume from 2016 to 2021

Figure Pakistan Human Vaccine Consumption Volume from 2016 to 2021

Figure Bangladesh Human Vaccine Consumption Volume from 2016 to 2021

Figure Southeast Asia Human Vaccine Consumption and Growth Rate (2016-2021)

Figure Southeast Asia Human Vaccine Revenue and Growth Rate (2016-2021)

Table Southeast Asia Human Vaccine Sales Price Analysis (2016-2021)

Table Southeast Asia Human Vaccine Consumption Volume by Types

Table Southeast Asia Human Vaccine Consumption Structure by Application

Table Southeast Asia Human Vaccine Consumption by Top Countries

Figure Indonesia Human Vaccine Consumption Volume from 2016 to 2021

Figure Thailand Human Vaccine Consumption Volume from 2016 to 2021

Figure Singapore Human Vaccine Consumption Volume from 2016 to 2021

Figure Malaysia Human Vaccine Consumption Volume from 2016 to 2021

Figure Philippines Human Vaccine Consumption Volume from 2016 to 2021

Figure Vietnam Human Vaccine Consumption Volume from 2016 to 2021

Figure Myanmar Human Vaccine Consumption Volume from 2016 to 2021

Figure Middle East Human Vaccine Consumption and Growth Rate (2016-2021)

Figure Middle East Human Vaccine Revenue and Growth Rate (2016-2021)

Table Middle East Human Vaccine Sales Price Analysis (2016-2021)

Table Middle East Human Vaccine Consumption Volume by Types

Table Middle East Human Vaccine Consumption Structure by Application

Table Middle East Human Vaccine Consumption by Top Countries

Figure Turkey Human Vaccine Consumption Volume from 2016 to 2021

Figure Saudi Arabia Human Vaccine Consumption Volume from 2016 to 2021

Figure Iran Human Vaccine Consumption Volume from 2016 to 2021

Figure United Arab Emirates Human Vaccine Consumption Volume from 2016 to 2021

Figure Israel Human Vaccine Consumption Volume from 2016 to 2021

Figure Iraq Human Vaccine Consumption Volume from 2016 to 2021

Figure Qatar Human Vaccine Consumption Volume from 2016 to 2021

Figure Kuwait Human Vaccine Consumption Volume from 2016 to 2021

Figure Oman Human Vaccine Consumption Volume from 2016 to 2021

Figure Africa Human Vaccine Consumption and Growth Rate (2016-2021)

Figure Africa Human Vaccine Revenue and Growth Rate (2016-2021)

Table Africa Human Vaccine Sales Price Analysis (2016-2021)

Table Africa Human Vaccine Consumption Volume by Types

Table Africa Human Vaccine Consumption Structure by Application

Table Africa Human Vaccine Consumption by Top Countries

Figure Nigeria Human Vaccine Consumption Volume from 2016 to 2021

Figure South Africa Human Vaccine Consumption Volume from 2016 to 2021

Figure Egypt Human Vaccine Consumption Volume from 2016 to 2021

Figure Algeria Human Vaccine Consumption Volume from 2016 to 2021

Figure Algeria Human Vaccine Consumption Volume from 2016 to 2021

Figure Oceania Human Vaccine Consumption and Growth Rate (2016-2021)

Figure Oceania Human Vaccine Revenue and Growth Rate (2016-2021)

Table Oceania Human Vaccine Sales Price Analysis (2016-2021)

Table Oceania Human Vaccine Consumption Volume by Types

Table Oceania Human Vaccine Consumption Structure by Application

Table Oceania Human Vaccine Consumption by Top Countries

Figure Australia Human Vaccine Consumption Volume from 2016 to 2021

Figure New Zealand Human Vaccine Consumption Volume from 2016 to 2021

Figure South America Human Vaccine Consumption and Growth Rate (2016-2021)

Figure South America Human Vaccine Revenue and Growth Rate (2016-2021)

Table South America Human Vaccine Sales Price Analysis (2016-2021)

Table South America Human Vaccine Consumption Volume by Types

Table South America Human Vaccine Consumption Structure by Application

Table South America Human Vaccine Consumption Volume by Major Countries

Figure Brazil Human Vaccine Consumption Volume from 2016 to 2021

Figure Argentina Human Vaccine Consumption Volume from 2016 to 2021

Figure Columbia Human Vaccine Consumption Volume from 2016 to 2021

Figure Chile Human Vaccine Consumption Volume from 2016 to 2021

Figure Venezuela Human Vaccine Consumption Volume from 2016 to 2021

Figure Peru Human Vaccine Consumption Volume from 2016 to 2021

Figure Puerto Rico Human Vaccine Consumption Volume from 2016 to 2021

Figure Ecuador Human Vaccine Consumption Volume from 2016 to 2021

CNBG Human Vaccine Product Specification

CNBG Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Changsheng Life Human Vaccine Product Specification

Changsheng Life Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Zhifei Human Vaccine Product Specification

Zhifei Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

ChengDa Bio Human Vaccine Product Specification

Table ChengDa Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Kangtai Human Vaccine Product Specification

Kangtai Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

SINOVAC BIOTECH Human Vaccine Product Specification

SINOVAC BIOTECH Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Hissen Human Vaccine Product Specification

Hissen Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Walvax Biotechnology Human Vaccine Product Specification

Walvax Biotechnology Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

GSK Human Vaccine Product Specification

GSK Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

SANOFI Human Vaccine Product Specification

SANOFI Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Rong An Human Vaccine Product Specification

Rong An Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

NuoCheng Bio Human Vaccine Product Specification

NuoCheng Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Hualan Bio Human Vaccine Product Specification

Hualan Bio Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Tiantan biological Human Vaccine Product Specification

Tiantan biological Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Changchun Baike Human Vaccine Product Specification

Changchun Baike Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Adimmune Human Vaccine Product Specification

Adimmune Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Zhongyianke Biotech Human Vaccine Product Specification

Zhongyianke Biotech Human Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Figure Global Human Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)

Figure Global Human Vaccine Value and Growth Rate Forecast (2022-2027)

Table Global Human Vaccine Consumption Volume Forecast by Regions (2022-2027)

Table Global Human Vaccine Value Forecast by Regions (2022-2027)

Figure North America Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure North America Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure United States Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure United States Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Canada Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Canada Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Mexico Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Mexico Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure East Asia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure East Asia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure China Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure China Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Japan Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Japan Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure South Korea Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure South Korea Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Europe Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Europe Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Germany Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Germany Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure UK Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure UK Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure France Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure France Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Italy Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Italy Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Russia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Russia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Spain Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Spain Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Netherlands Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Netherlands Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Swizerland Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Swizerland Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Poland Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Poland Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure South Asia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure South Asia a Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure India Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure India Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Pakistan Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Pakistan Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Bangladesh Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Bangladesh Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Southeast Asia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Southeast Asia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Indonesia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Indonesia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Thailand Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Thailand Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Singapore Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Singapore Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Malaysia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Malaysia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Philippines Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Philippines Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Vietnam Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Vietnam Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Myanmar Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Myanmar Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Middle East Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Middle East Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Turkey Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Turkey Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Saudi Arabia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Saudi Arabia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Iran Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Iran Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure United Arab Emirates Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure United Arab Emirates Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Israel Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Israel Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Iraq Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Iraq Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Qatar Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Qatar Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Kuwait Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Kuwait Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Oman Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Oman Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Africa Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Africa Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Nigeria Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Nigeria Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure South Africa Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure South Africa Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Egypt Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Egypt Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Algeria Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Algeria Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Morocco Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Morocco Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Oceania Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Oceania Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Australia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Australia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure New Zealand Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure New Zealand Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure South America Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure South America Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Brazil Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Brazil Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Argentina Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Argentina Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Columbia Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Columbia Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Chile Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Chile Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Venezuela Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Venezuela Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Peru Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Peru Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Puerto Rico Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Puerto Rico Human Vaccine Value and Growth Rate Forecast (2022-2027)

Figure Ecuador Human Vaccine Consumption and Growth Rate Forecast (2022-2027)

Figure Ecuador Human Vaccine Value and Growth Rate Forecast (2022-2027)

Table Global Human Vaccine Consumption Forecast by Type (2022-2027)

Table Global Human Vaccine Revenue Forecast by Type (2022-2027)

Figure Global Human Vaccine Price Forecast by Type (2022-2027)

Table Global Human Vaccine Consumption Volume Forecast by Application (2022-2027)